ICU Medical Inc (ICUI) Com Stk USD0.10
ICU Medical, Inc. (ICU) is engaged in the development, manufacturing and sale of medical products used in infusion therapy and critical care applications. The Company’s product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. Its critical care products help clinicians get real-time access to patients’ hemodynamic and cardiac status with a portfolio of monitoring systems and advanced sensors and catheters. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. It sells its products through its direct sales force and through independent distributors. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.